Skip to main content
Top
Published in: BMC Infectious Diseases 1/2015

Open Access 01-12-2015 | Research article

Nationwide prevalence of human papillomavirus infection and viral genotype distribution in 37 cities in China

Authors: Rong Wang, Xiao-lei Guo, G. Bea. A. Wisman, Ed Schuuring, Wen-feng Wang, Zheng-yu Zeng, Hong Zhu, Shang-wei Wu

Published in: BMC Infectious Diseases | Issue 1/2015

Login to get access

Abstract

Background

Type-specific high-risk HPV (hrHPV) infection is related to cervical carcinogenesis. The prevalence of hrHPV infection varies geographically, which might reflect the epidemiological characteristics of cervical cancer among different populations. To establish a foundation for HPV-based screening and vaccination programs in China, we investigated the most recent HPV prevalence and genotypic distributions in different female age groups and geographical regions in China.

Methods

In 2012, a total of 120,772 liquid-based cytological samples from women enrolled for population- or employee-based cervical screening in 37 Chinese cities were obtained by the Laboratory of Molecular Infectious Diseases of Guangzhou KingMed. A total of 111,131 samples were tested by Hybrid Capture II and the other 9,641 were genotyped using the Tellgenplex™ HPV DNA Assay.

Results

The total positive rate for hrHPV was 21.07 %, which ranged from 18.42 % (Nanchang) to 31.94 % (Haikou) and varied by region. The regions of Nanchang, Changsha, Hangzhou, Chengdu, Fuzhou, Guangdong, and Guiyang could be considered the low prevalence regions. Age-specific prevalence showed a “two-peak” pattern, with the youngest age group (15–19 years) presenting the highest hrHPV infection rate (30.55 %), followed by a second peak for the 50–60-year-old group. Overall, the most prevalent genotypes were HPV16 (4.82 %) and HPV52 (4.52 %), followed by HPV58 (2.74 %). Two genotypes HPV6 (4.01 %) and HPV11 (2.29 %) were predominant in the low-risk HPV (lrHPV) type, while the mixed genotypes HPV16 + 52 and HPV52 + 58 were most common in women with multiple infections.

Conclusions

This study shows that HPV infection in China has increased to the level of an “HPV-heavy-burden” zone in certain regions, with prevalence varying significantly among different ages and regions. Data from this study represent the most current survey of the nationwide prevalence of HPV infection in China, and can serve as valuable reference to guide nationwide cervical cancer screening and HPV vaccination programs.
Appendix
Available only for authorised users
Literature
1.
2.
go back to reference Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA: a cancer journal for clinicians. 2011;61(2):69–90. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA: a cancer journal for clinicians. 2011;61(2):69–90.
3.
go back to reference Priebe AM. 2012 cervical cancer screening guidelines and the future role of HPV testing. Clinical obstetrics and gynecology. 2013;56(1):44–50.CrossRefPubMed Priebe AM. 2012 cervical cancer screening guidelines and the future role of HPV testing. Clinical obstetrics and gynecology. 2013;56(1):44–50.CrossRefPubMed
4.
go back to reference Papillomavirus H, Cancers R. WHO/ICO HPV information centre summary report (september 15. 2010. Papillomavirus H, Cancers R. WHO/ICO HPV information centre summary report (september 15. 2010.
5.
go back to reference Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International journal of cancer Journal international du cancer. 2010;127(12):2893–917.CrossRefPubMed Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International journal of cancer Journal international du cancer. 2010;127(12):2893–917.CrossRefPubMed
6.
go back to reference Internation Agency for Research on Cancer(IRAC). IARC handbooks of cancer prevention: cervix cancer screening, chapter 2. Lyon: IARC Press.2005;10:1-299 Internation Agency for Research on Cancer(IRAC). IARC handbooks of cancer prevention: cervix cancer screening, chapter 2. Lyon: IARC Press.2005;10:1-299
7.
go back to reference de Villiers EM, Fauquet C, Broker TR. Bernard HU, zur Hausen H: Classification of papillomaviruses. Virology. 2004;324(1):17–27.CrossRefPubMed de Villiers EM, Fauquet C, Broker TR. Bernard HU, zur Hausen H: Classification of papillomaviruses. Virology. 2004;324(1):17–27.CrossRefPubMed
8.
go back to reference Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. The New England journal of medicine. 2003;348(6):518–27.CrossRefPubMed Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. The New England journal of medicine. 2003;348(6):518–27.CrossRefPubMed
9.
go back to reference Castle PE, de Sanjose S, Qiao YL, Belinson JL, Lazcano-Ponce E, Kinney W. Introduction of human papillomavirus DNA screening in the world: 15 years of experience. Vaccine. 2012;30 Suppl 5:F117–122.CrossRefPubMed Castle PE, de Sanjose S, Qiao YL, Belinson JL, Lazcano-Ponce E, Kinney W. Introduction of human papillomavirus DNA screening in the world: 15 years of experience. Vaccine. 2012;30 Suppl 5:F117–122.CrossRefPubMed
10.
go back to reference Herrero R. Human papillomavirus (HPV) vaccines: limited cross-protection against additional HPV types. The Journal of infectious diseases. 2009;199(7):919–22.CrossRefPubMed Herrero R. Human papillomavirus (HPV) vaccines: limited cross-protection against additional HPV types. The Journal of infectious diseases. 2009;199(7):919–22.CrossRefPubMed
11.
go back to reference de Sanjose S, Diaz M, Castellsague X, Clifford G, Bruni L, Munoz N, et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. The Lancet infectious diseases. 2007;7(7):453–9.CrossRefPubMed de Sanjose S, Diaz M, Castellsague X, Clifford G, Bruni L, Munoz N, et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. The Lancet infectious diseases. 2007;7(7):453–9.CrossRefPubMed
12.
go back to reference Krul EJ, Van De Vijver MJ, Schuuring E, Van Kanten RW, Peters AA, Fleuren GJ. Human papillomavirus in malignant cervical lesions in Surinam, a high-risk country, compared to the Netherlands, a low-risk country. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 1999;9(3):206–11.CrossRef Krul EJ, Van De Vijver MJ, Schuuring E, Van Kanten RW, Peters AA, Fleuren GJ. Human papillomavirus in malignant cervical lesions in Surinam, a high-risk country, compared to the Netherlands, a low-risk country. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 1999;9(3):206–11.CrossRef
13.
go back to reference Kliucinskas M, Nadisauskiene RJ, Minkauskiene M. Prevalence and risk factors of HPV infection among high-risk rural and urban Lithuanian women. Gynecologic and obstetric investigation. 2006;62(3):173–80.CrossRefPubMed Kliucinskas M, Nadisauskiene RJ, Minkauskiene M. Prevalence and risk factors of HPV infection among high-risk rural and urban Lithuanian women. Gynecologic and obstetric investigation. 2006;62(3):173–80.CrossRefPubMed
14.
go back to reference Belinson J, Qiao Y, Pretorius R, Zhang W, Keaton K, Elson P, et al. Prevalence of cervical cancer and feasibility of screening in rural China: a pilot study for the Shanxi Province Cervical Cancer Screening Study. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 1999;9(5):411–7.CrossRef Belinson J, Qiao Y, Pretorius R, Zhang W, Keaton K, Elson P, et al. Prevalence of cervical cancer and feasibility of screening in rural China: a pilot study for the Shanxi Province Cervical Cancer Screening Study. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 1999;9(5):411–7.CrossRef
15.
go back to reference Li J, Huang R, Schmidt JE, Qiao YL. Epidemiological features of Human Papillomavirus (HPV) infection among women living in Mainland China. Asian Pacific journal of cancer prevention : APJCP. 2013;14(7):4015–23.CrossRefPubMed Li J, Huang R, Schmidt JE, Qiao YL. Epidemiological features of Human Papillomavirus (HPV) infection among women living in Mainland China. Asian Pacific journal of cancer prevention : APJCP. 2013;14(7):4015–23.CrossRefPubMed
16.
go back to reference Zhao R, Zhang WY, Zhang SW, Wu MH, Wang JD, Xie Z, et al. Study on subtype of human papillomavirus infection among aged 25–54 reproductive women in Beijing from 2006 to 2008. Zhonghua fu chan ke za zhi. 2011;46(3):184–7.PubMed Zhao R, Zhang WY, Zhang SW, Wu MH, Wang JD, Xie Z, et al. Study on subtype of human papillomavirus infection among aged 25–54 reproductive women in Beijing from 2006 to 2008. Zhonghua fu chan ke za zhi. 2011;46(3):184–7.PubMed
17.
go back to reference Wu D, Cai L, Huang M, Zheng Y, Yu J. Prevalence of genital human papillomavirus infection and genotypes among women from Fujian province, PR China. European journal of obstetrics, gynecology, and reproductive biology. 2010;151(1):86–90.CrossRefPubMed Wu D, Cai L, Huang M, Zheng Y, Yu J. Prevalence of genital human papillomavirus infection and genotypes among women from Fujian province, PR China. European journal of obstetrics, gynecology, and reproductive biology. 2010;151(1):86–90.CrossRefPubMed
18.
go back to reference Li J, Mei J, Wang X, Hu L, Lin Y, Yang P. Human papillomavirus type-specific prevalence in women with cervical intraepithelial neoplasm in Western China. Journal of clinical microbiology. 2012;50(3):1079–81.CrossRefPubMedPubMedCentral Li J, Mei J, Wang X, Hu L, Lin Y, Yang P. Human papillomavirus type-specific prevalence in women with cervical intraepithelial neoplasm in Western China. Journal of clinical microbiology. 2012;50(3):1079–81.CrossRefPubMedPubMedCentral
19.
go back to reference Han J, Swan DC, Smith SJ, Lum SH, Sefers SE, Unger ER, et al. Simultaneous amplification and identification of 25 human papillomavirus types with Templex technology. Journal of clinical microbiology. 2006;44(11):4157–62.CrossRefPubMedPubMedCentral Han J, Swan DC, Smith SJ, Lum SH, Sefers SE, Unger ER, et al. Simultaneous amplification and identification of 25 human papillomavirus types with Templex technology. Journal of clinical microbiology. 2006;44(11):4157–62.CrossRefPubMedPubMedCentral
20.
go back to reference Boers A, Slagter-Menkema L, van Hemel BM, Belinson JL, Ruitenbeek T, Buikema HJ, et al. Comparing the Cervista HPV HR test and Hybrid Capture 2 assay in a Dutch screening population: improved specificity of the Cervista HPV HR test by changing the cut-off. PloS one. 2014;9(7), e101930.CrossRefPubMedPubMedCentral Boers A, Slagter-Menkema L, van Hemel BM, Belinson JL, Ruitenbeek T, Buikema HJ, et al. Comparing the Cervista HPV HR test and Hybrid Capture 2 assay in a Dutch screening population: improved specificity of the Cervista HPV HR test by changing the cut-off. PloS one. 2014;9(7), e101930.CrossRefPubMedPubMedCentral
21.
go back to reference Boers A, Wang R, Slagter-Menkema L, van Hemel BM, Ghyssaert H, van der Zee AG, et al. Clinical validation of the Cervista HPV HR test according to the international guidelines for human papillomavirus test requirements for cervical cancer screening. Journal of clinical microbiology. 2014;52(12):4391–3.CrossRefPubMedPubMedCentral Boers A, Wang R, Slagter-Menkema L, van Hemel BM, Ghyssaert H, van der Zee AG, et al. Clinical validation of the Cervista HPV HR test according to the international guidelines for human papillomavirus test requirements for cervical cancer screening. Journal of clinical microbiology. 2014;52(12):4391–3.CrossRefPubMedPubMedCentral
22.
go back to reference Wei W, Shi Q, Guo F, Zhang BY, Chen C, Zhang NS, et al. The distribution of human papillomavirus in tissues from patients with head and neck squamous cell carcinoma. Oncology reports. 2012;28(5):1750–6.PubMed Wei W, Shi Q, Guo F, Zhang BY, Chen C, Zhang NS, et al. The distribution of human papillomavirus in tissues from patients with head and neck squamous cell carcinoma. Oncology reports. 2012;28(5):1750–6.PubMed
23.
go back to reference Hu Y, Qian HZ, Sun J, Gao L, Yin L, Li X, et al. Anal human papillomavirus infection among HIV-infected and uninfected men who have sex with men in Beijing. China J Acquir Immune Defic Syndr. 2013;64(1):103–14.CrossRefPubMed Hu Y, Qian HZ, Sun J, Gao L, Yin L, Li X, et al. Anal human papillomavirus infection among HIV-infected and uninfected men who have sex with men in Beijing. China J Acquir Immune Defic Syndr. 2013;64(1):103–14.CrossRefPubMed
24.
go back to reference Ludbrook J. Multiple comparison procedures updated. Clinical and experimental pharmacology & physiology. 1998;25(12):1032–7.CrossRef Ludbrook J. Multiple comparison procedures updated. Clinical and experimental pharmacology & physiology. 1998;25(12):1032–7.CrossRef
25.
go back to reference Bruni L, Diaz M, Castellsague X, Ferrer E, Bosch FX, de Sanjose S. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. The Journal of infectious diseases. 2010;202(12):1789–99.CrossRefPubMed Bruni L, Diaz M, Castellsague X, Ferrer E, Bosch FX, de Sanjose S. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. The Journal of infectious diseases. 2010;202(12):1789–99.CrossRefPubMed
26.
go back to reference Bayo S, Bosch FX, de Sanjose S, Munoz N, Combita AL, Coursaget P, et al. Risk factors of invasive cervical cancer in Mali. International journal of epidemiology. 2002;31(1):202–9.CrossRefPubMed Bayo S, Bosch FX, de Sanjose S, Munoz N, Combita AL, Coursaget P, et al. Risk factors of invasive cervical cancer in Mali. International journal of epidemiology. 2002;31(1):202–9.CrossRefPubMed
27.
go back to reference Zhao FH, Lewkowitz AK, Hu SY, Chen F, Li LY, Zhang QM, et al. Prevalence of human papillomavirus and cervical intraepithelial neoplasia in China: a pooled analysis of 17 population-based studies. International journal of cancer Journal international du cancer. 2012;131(12):2929–38.CrossRefPubMedPubMedCentral Zhao FH, Lewkowitz AK, Hu SY, Chen F, Li LY, Zhang QM, et al. Prevalence of human papillomavirus and cervical intraepithelial neoplasia in China: a pooled analysis of 17 population-based studies. International journal of cancer Journal international du cancer. 2012;131(12):2929–38.CrossRefPubMedPubMedCentral
28.
go back to reference Wu EQ, Liu B, Cui JF, Chen W, Wang JB, Lu L, et al. Prevalence of type-specific human papillomavirus and pap results in Chinese women: a multi-center, population-based cross-sectional study. Cancer causes & control : CCC. 2013;24(4):795–803.CrossRefPubMed Wu EQ, Liu B, Cui JF, Chen W, Wang JB, Lu L, et al. Prevalence of type-specific human papillomavirus and pap results in Chinese women: a multi-center, population-based cross-sectional study. Cancer causes & control : CCC. 2013;24(4):795–803.CrossRefPubMed
29.
go back to reference Zhang R, Shi TY, Ren Y, Lu H, Wei ZH, Hou WJ, et al. Risk factors for human papillomavirus infection in Shanghai suburbs: a population-based study with 10,000 women. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology. 2013;58(1):144–8.CrossRef Zhang R, Shi TY, Ren Y, Lu H, Wei ZH, Hou WJ, et al. Risk factors for human papillomavirus infection in Shanghai suburbs: a population-based study with 10,000 women. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology. 2013;58(1):144–8.CrossRef
30.
go back to reference Chen Q, Xie LX, Qing ZR, Li LJ, Luo ZY, Lin M, et al. Epidemiologic characterization of human papillomavirus infection in rural Chaozhou, eastern Guangdong Province of China. PloS one. 2012;7(2), e32149.CrossRefPubMedPubMedCentral Chen Q, Xie LX, Qing ZR, Li LJ, Luo ZY, Lin M, et al. Epidemiologic characterization of human papillomavirus infection in rural Chaozhou, eastern Guangdong Province of China. PloS one. 2012;7(2), e32149.CrossRefPubMedPubMedCentral
31.
go back to reference Wu RF, Dai M, Qiao YL, Clifford GM, Liu ZH, Arslan A, et al. Human papillomavirus infection in women in Shenzhen City, People's Republic of China, a population typical of recent Chinese urbanisation. International journal of cancer Journal international du cancer. 2007;121(6):1306–11.CrossRefPubMed Wu RF, Dai M, Qiao YL, Clifford GM, Liu ZH, Arslan A, et al. Human papillomavirus infection in women in Shenzhen City, People's Republic of China, a population typical of recent Chinese urbanisation. International journal of cancer Journal international du cancer. 2007;121(6):1306–11.CrossRefPubMed
32.
go back to reference Ye J, Cheng X, Chen X, Ye F, Lu W, Xie X. Prevalence and risk profile of cervical Human papillomavirus infection in Zhejiang Province, southeast China: a population-based study. Virology journal. 2010;7:66.CrossRefPubMedPubMedCentral Ye J, Cheng X, Chen X, Ye F, Lu W, Xie X. Prevalence and risk profile of cervical Human papillomavirus infection in Zhejiang Province, southeast China: a population-based study. Virology journal. 2010;7:66.CrossRefPubMedPubMedCentral
33.
go back to reference Baseman JG, Koutsky LA. The epidemiology of human papillomavirus infections. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology. 2005;32 Suppl 1:S16–24.CrossRef Baseman JG, Koutsky LA. The epidemiology of human papillomavirus infections. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology. 2005;32 Suppl 1:S16–24.CrossRef
34.
go back to reference Hildesheim A, Wang SS. Host and viral genetics and risk of cervical cancer: a review. Virus research. 2002;89(2):229–40.CrossRefPubMed Hildesheim A, Wang SS. Host and viral genetics and risk of cervical cancer: a review. Virus research. 2002;89(2):229–40.CrossRefPubMed
35.
go back to reference Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. International journal of cancer Journal international du cancer. 2007;121(3):621–32.CrossRefPubMed Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. International journal of cancer Journal international du cancer. 2007;121(3):621–32.CrossRefPubMed
36.
go back to reference Cui M, Chan N, Liu M, Thai K, Malaczynska J, Singh I, et al. Clinical performance of Roche Cobas 4800 HPV Test. Journal of clinical microbiology. 2014;52(6):2210–1.CrossRefPubMedPubMedCentral Cui M, Chan N, Liu M, Thai K, Malaczynska J, Singh I, et al. Clinical performance of Roche Cobas 4800 HPV Test. Journal of clinical microbiology. 2014;52(6):2210–1.CrossRefPubMedPubMedCentral
37.
go back to reference Chen CY, Wang CH: Human papillomavirus type distribution in southern china and taiwan. Human papillomavirus and related diseases from bench to bedside-research aspects 2012;19-36 Chen CY, Wang CH: Human papillomavirus type distribution in southern china and taiwan. Human papillomavirus and related diseases from bench to bedside-research aspects 2012;19-36
38.
go back to reference Jing L, Zhong X, Huang W, Liu Y, Wang M, Miao Z, et al. HPV genotypes and associated cervical cytological abnormalities in women from the Pearl River Delta region of Guangdong province. China: a cross-sectional study BMC infectious diseases. 2014;14:388.PubMed Jing L, Zhong X, Huang W, Liu Y, Wang M, Miao Z, et al. HPV genotypes and associated cervical cytological abnormalities in women from the Pearl River Delta region of Guangdong province. China: a cross-sectional study BMC infectious diseases. 2014;14:388.PubMed
39.
go back to reference Guan P, Howell-Jones R, Li N, Bruni L, de Sanjose S, Franceschi S, et al. Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer. International journal of cancer Journal international du cancer. 2012;131(10):2349–59.CrossRefPubMed Guan P, Howell-Jones R, Li N, Bruni L, de Sanjose S, Franceschi S, et al. Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer. International journal of cancer Journal international du cancer. 2012;131(10):2349–59.CrossRefPubMed
40.
go back to reference Zhao FH, Tiggelaar SM, Hu SY, Xu LN, Hong Y, Niyazi M, et al. A multi-center survey of age of sexual debut and sexual behavior in Chinese women: suggestions for optimal age of human papillomavirus vaccination in China. Cancer epidemiology. 2012;36(4):384–90.CrossRefPubMed Zhao FH, Tiggelaar SM, Hu SY, Xu LN, Hong Y, Niyazi M, et al. A multi-center survey of age of sexual debut and sexual behavior in Chinese women: suggestions for optimal age of human papillomavirus vaccination in China. Cancer epidemiology. 2012;36(4):384–90.CrossRefPubMed
41.
go back to reference Wang S, Wei H, Wang N, Zhang S, Zhang Y, Ruan Q, et al. The prevalence and role of human papillomavirus genotypes in primary cervical screening in the northeast of China. BMC cancer. 2012;12:160.CrossRefPubMedPubMedCentral Wang S, Wei H, Wang N, Zhang S, Zhang Y, Ruan Q, et al. The prevalence and role of human papillomavirus genotypes in primary cervical screening in the northeast of China. BMC cancer. 2012;12:160.CrossRefPubMedPubMedCentral
42.
go back to reference Liu SS, Chan KY, Leung RC, Chan KK, Tam KF, Luk MH, et al. Prevalence and risk factors of Human Papillomavirus (HPV) infection in southern Chinese women - a population-based study. PloS one. 2011;6(5), e19244.CrossRefPubMedPubMedCentral Liu SS, Chan KY, Leung RC, Chan KK, Tam KF, Luk MH, et al. Prevalence and risk factors of Human Papillomavirus (HPV) infection in southern Chinese women - a population-based study. PloS one. 2011;6(5), e19244.CrossRefPubMedPubMedCentral
43.
go back to reference Hausen H. Papillomaviruses in the causation of human cancers - a brief historical account. Virology. 2009;38(2):260–5.CrossRef Hausen H. Papillomaviruses in the causation of human cancers - a brief historical account. Virology. 2009;38(2):260–5.CrossRef
44.
go back to reference Leto M, Santos Junior GF, Porro AM, Tomimori J. Human papillomavirus infection: etiopathogenesis, molecular biology and clinical manifestations. Anais brasileiros de dermatologia. 2011;86(2):306–17.CrossRefPubMed Leto M, Santos Junior GF, Porro AM, Tomimori J. Human papillomavirus infection: etiopathogenesis, molecular biology and clinical manifestations. Anais brasileiros de dermatologia. 2011;86(2):306–17.CrossRefPubMed
45.
go back to reference Preaud E, Largeron N: Economic burden of non-cervical cancers attributable to human papillomavirus: a European scoping review. Journal of medical economics 2013;16(6):763-76 Preaud E, Largeron N: Economic burden of non-cervical cancers attributable to human papillomavirus: a European scoping review. Journal of medical economics 2013;16(6):763-76
46.
go back to reference Lee SA, Kang D, Seo SS, Jeong JK, Yoo KY, Jeon YT, et al. Multiple HPV infection in cervical cancer screened by HPVDNAChip. Cancer letters. 2003;198(2):187–92.CrossRefPubMed Lee SA, Kang D, Seo SS, Jeong JK, Yoo KY, Jeon YT, et al. Multiple HPV infection in cervical cancer screened by HPVDNAChip. Cancer letters. 2003;198(2):187–92.CrossRefPubMed
47.
go back to reference Schmitt M, Depuydt C, Benoy I, Bogers J, Antoine J, Arbyn M, Pawlita M: Multiple HPV infections with high viral loads are associated with cervical lesions but do not differentiate grades of cervical abnormalities. Journal of clinical microbiology 2013;51(5):1458-64. Schmitt M, Depuydt C, Benoy I, Bogers J, Antoine J, Arbyn M, Pawlita M: Multiple HPV infections with high viral loads are associated with cervical lesions but do not differentiate grades of cervical abnormalities. Journal of clinical microbiology 2013;51(5):1458-64.
48.
go back to reference Gage JC, Ajenifuja KO, Wentzensen NA, Adepiti AC, Eklund C, Reilly M, et al. The age-specific prevalence of human papillomavirus and risk of cytologic abnormalities in rural Nigeria: implications for screen-and-treat strategies. International journal of cancer Journal international du cancer. 2012;130(9):2111–7.CrossRefPubMed Gage JC, Ajenifuja KO, Wentzensen NA, Adepiti AC, Eklund C, Reilly M, et al. The age-specific prevalence of human papillomavirus and risk of cytologic abnormalities in rural Nigeria: implications for screen-and-treat strategies. International journal of cancer Journal international du cancer. 2012;130(9):2111–7.CrossRefPubMed
49.
go back to reference Munson E, Du Chateau BK, Bellerose B, Czarnecka J, Griep J. Clinical laboratory evaluation of Invader(R) chemistry and hybrid capture for detection of high-risk human papillomavirus in liquid-based cytology specimens. Diagnostic microbiology and infectious disease. 2011;71(3):230–5.CrossRefPubMed Munson E, Du Chateau BK, Bellerose B, Czarnecka J, Griep J. Clinical laboratory evaluation of Invader(R) chemistry and hybrid capture for detection of high-risk human papillomavirus in liquid-based cytology specimens. Diagnostic microbiology and infectious disease. 2011;71(3):230–5.CrossRefPubMed
Metadata
Title
Nationwide prevalence of human papillomavirus infection and viral genotype distribution in 37 cities in China
Authors
Rong Wang
Xiao-lei Guo
G. Bea. A. Wisman
Ed Schuuring
Wen-feng Wang
Zheng-yu Zeng
Hong Zhu
Shang-wei Wu
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2015
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-015-0998-5

Other articles of this Issue 1/2015

BMC Infectious Diseases 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.